These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1971432

  • 1. Clonidine, administered intracerebroventricularly in mice, produces an anti-analgesic effect which may be mediated spinally by dynorphin A (1-17).
    Fujimoto JM, Arts KS.
    Neuropharmacology; 1990 Apr; 29(4):351-8. PubMed ID: 1971432
    [Abstract] [Full Text] [Related]

  • 2. Dynorphin A(1-17) mediates midazolam antagonism of morphine antinociception in mice.
    Rady JJ, Fujimoto JM.
    Pharmacol Biochem Behav; 1993 Oct; 46(2):331-9. PubMed ID: 7903457
    [Abstract] [Full Text] [Related]

  • 3. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
    Fujimoto JM, Rady JJ.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
    [Abstract] [Full Text] [Related]

  • 4. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
    Fujimoto JM, Arts KS, Rady JJ, Tseng LF.
    Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
    [Abstract] [Full Text] [Related]

  • 5. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T, Furuya Y, Kaneko T, Yamatsu K.
    J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
    [Abstract] [Full Text] [Related]

  • 6. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
    Rady JJ, Holmes BB, Fujimoto JM.
    Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
    [Abstract] [Full Text] [Related]

  • 7. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
    Holmes BB, Fujimoto JM.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
    [Abstract] [Full Text] [Related]

  • 8. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the antianalgesic action of dynorphin A in mice by cholera toxin.
    Arts KS, Fujimoto JM, Crain SM.
    Pharmacol Biochem Behav; 1993 Nov; 46(3):623-9. PubMed ID: 7904072
    [Abstract] [Full Text] [Related]

  • 10. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
    Song ZH, Takemori AE.
    Life Sci; 1991 Nov; 48(15):1447-53. PubMed ID: 1672725
    [Abstract] [Full Text] [Related]

  • 11. Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A.
    Aksu F, Holmes BB, Fujimoto JM.
    Pharmacol Biochem Behav; 1993 Jun; 45(2):409-18. PubMed ID: 8101007
    [Abstract] [Full Text] [Related]

  • 12. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF, Collins KA.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [Abstract] [Full Text] [Related]

  • 13. Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
    Suh HH, Tseng LL.
    Neuropharmacology; 1990 Mar; 29(3):207-14. PubMed ID: 2139187
    [Abstract] [Full Text] [Related]

  • 14. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
    Arts KS, Fujimoto JM, Tseng LF.
    J Pharmacol Exp Ther; 1992 May; 261(2):643-51. PubMed ID: 1374471
    [Abstract] [Full Text] [Related]

  • 15. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC, Lei S, Kitto K, Hylden JK, Wilcox GL.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [Abstract] [Full Text] [Related]

  • 16. The antinociceptive activity of intrathecally administered amiloride and its interactions with morphine and clonidine in rats.
    Ouyang H, Bai X, Huang W, Chen D, Dohi S, Zeng W.
    J Pain; 2012 Jan; 13(1):41-8. PubMed ID: 22154330
    [Abstract] [Full Text] [Related]

  • 17. Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice.
    Holmes BB, Fujimoto JM.
    Anesth Analg; 1993 Dec; 77(6):1166-73. PubMed ID: 7902680
    [Abstract] [Full Text] [Related]

  • 18. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
    Rady JJ, Holmes BB, Fujimoto JM.
    Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
    [Abstract] [Full Text] [Related]

  • 19. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
    Song SH, Takemori AE.
    Life Sci; 1992 Mar; 51(2):107-11. PubMed ID: 1352026
    [Abstract] [Full Text] [Related]

  • 20. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
    Wang FS, Fujimoto JM.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1361-8. PubMed ID: 8099619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.